WARFIGHTER SCREENING
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FA2396 USAF AFMC AFRL PZL AFRL PZLE
Contract Value
Not provided
Codes & Classification
Solicitation Number
SS-AFRL-PZLEQ-2026-0004
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents2
The Department of the Air Force, under the Air Force Materiel Command (AFMC) and the Air Force Research Laboratory (AFRL), has issued a Sources Sought notice titled "WARFIGHTER SCREENING." This preliminary market research effort seeks to identify potential sources capable of supporting requirements related to in-vitro diagnostic substance manufacturing, as classified under NAICS Code 325413 (2022 version). The associated Product Service Code is 6550, which pertains to in-vitro diagnostic substances.
The intended place of performance for this requirement is Wright Patterson Air Force Base (AFB) in Ohio, United States. The procurement is managed by the AFRL PZLE office, with primary and secondary points of contact provided for interested parties: Mike Hornberger ([email protected], 937-713-0549) and Jessica Briggs ([email protected]).
As a Sources Sought notice, this announcement is not a solicitation for proposals but rather an invitation for industry feedback and capability statements. The government is seeking to understand the availability and capabilities of qualified vendors who can provide products or services related to warfighter screening using in-vitro diagnostic substances. The scope likely involves the development, manufacturing, or supply of diagnostic materials or systems that support the health, readiness, or operational effectiveness of military personnel, though specific requirements and deliverables are not detailed in the notice.
Interested contractors should note that this opportunity is in the early stages of the procurement lifecycle, with the government gathering information to inform future acquisition strategies. There are no set-aside requirements or special considerations specified at this time. The notice remains active, with a response deadline of January 28, 2026, at 20:01. Contractors are encouraged to review the two attachments referenced in the notice for additional context and to submit capability statements or expressions of interest as appropriate.
This opportunity is particularly relevant for organizations with expertise in in-vitro diagnostic substance manufacturing and a track record of supporting federal or defense-related health screening initiatives. The contracting entity is a federal office within the Department of Defense, and all communications should be directed to the provided contacts at AFRL PZLE. For further details and to access the attachments, interested parties should visit the official notice page on SAM.gov using Opportunity ID a839aabb5c8240d9960ec75b7871369e.